St. Louis, MO 的 結腸癌 臨床試驗
15 項針對 結腸癌 的研究正在 St. Louis（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Family Communications After Genetic Testing
招募中歡迎健康志工
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- 還有 4 項
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
招募中歡迎健康志工
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- 還有 4 項
A Study of PHN-012 in Patients With Advanced Solid Tumors
招募中1 期
- PHN-012-001 Site, St Louis
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
招募中3 期
- Washington University School of Medicine, St Louis
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
招募中2 期
- Missouri Baptist, St Louis
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
招募中觀察性研究
- Washington University School of Medicine, St Louis
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
招募中
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
- 還有 1 項
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
招募中2/3 期
- Mercy Infusion Center - Chippewa, St Louis
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- 還有 8 項
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
招募中
- Washington University School of Medicine, St Louis
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
招募中1/2 期
- Washington University, St Louis
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
招募中1 期
- Research Site, St Louis
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
招募中1/2 期
- Washington University Infusion Center Pharmacy, St Louis
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
招募中觀察性研究歡迎健康志工
- Washington University School of Medicine, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
招募中1/2 期
- Washington University, St Louis
其他城市的 結腸癌 試驗
- Boston, MA22 項研究
- New York City, NY22 項研究
- Houston, TX20 項研究
- Los Angeles, CA16 項研究
- Nashville, TN16 項研究
- Arlington, VA15 項研究
- Chicago, IL14 項研究
- San Antonio, TX14 項研究
- Baldwin Park, CA14 項研究
- Baltimore, MD13 項研究
- Tampa, FL13 項研究
- Washington, DC12 項研究
St. Louis 的其他研究
- 非小細胞肺癌73 項研究
- 乳癌64 項研究
- 轉移性癌症54 項研究
- 大腸直腸癌50 項研究
- 癌症（所有類型）46 項研究
- 前列腺癌46 項研究
- 肺癌39 項研究
- 卵巢癌38 項研究
- 胰臟癌33 項研究
- 子宮內膜癌29 項研究
- 頭頸部鱗狀細胞癌28 項研究
- 心臟衰竭26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。